-
1دورية أكاديمية
المؤلفون: Grimmelmann I., Momma M., Zimmer L., Hassel J. C., Heinzerling L., Pfohler C., Loquai C., Ruini C., Utikal J., Thoms K. -M., Kahler K. C., Eigentler T., Herbst R. A., Meier F., Debus D., Berking C., Kochanek C., Ugurel S., Gutzmer R.
المساهمون: Grimmelmann, I., Momma, M., Zimmer, L., Hassel, J. C., Heinzerling, L., Pfohler, C., Loquai, C., Ruini, C., Utikal, J., Thoms, K. -M., Kahler, K. C., Eigentler, T., Herbst, R. A., Meier, F., Debus, D., Berking, C., Kochanek, C., Ugurel, S., Gutzmer, R.
مصطلحات موضوعية: diabete, diabetes mellitu, immune checkpoint inhibitor, immune-related adverse event, ipilimumab, lipase, nivolumab, pancreatiti, pd-1 inhibitor, pembrolizumab, adult, aged, 80 and over, biomarker, blood glucose, type 1, exocrine pancreatic insufficiency, female, germany, human, male, melanoma, middle aged, predictive value of test, retrospective studie, skin neoplasm, time factor, treatment outcome, up-regulation, young adult
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/33812141; info:eu-repo/semantics/altIdentifier/wos/WOS:000647678000001; volume:149; firstpage:1; lastpage:10; numberofpages:10; journal:EUROPEAN JOURNAL OF CANCER; https://hdl.handle.net/11573/1682141Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85105295200
-
2دورية أكاديمية
المؤلفون: Grimmelmann I., Momma M., Zimmer L., Hassel J. C., Heinzerling L., Pfohler C., Loquai C., Ruini C., Utikal J., Thoms K. -M., Kahler K. C., Eigentler T., Herbst R. A., Meier F., Debus D., Berking C., Kochanek C., Ugurel S., Gutzmer R.
المساهمون: Grimmelmann, I., Momma, M., Zimmer, L., Hassel, J. C., Heinzerling, L., Pfohler, C., Loquai, C., Ruini, C., Utikal, J., Thoms, K. -M., Kahler, K. C., Eigentler, T., Herbst, R. A., Meier, F., Debus, D., Berking, C., Kochanek, C., Ugurel, S., Gutzmer, R.
مصطلحات موضوعية: Diabete, Diabetes mellitu, Immune checkpoint inhibitor, Immune-related adverse event, Ipilimumab, Lipase, Nivolumab, Pancreatiti, PD-1 inhibitor, Pembrolizumab, Adult, Aged, 80 and over, Biomarker, Blood Glucose, Diabetes Mellitus, Type 1, Exocrine Pancreatic Insufficiency, Female, Germany, Human, Male, Melanoma, Middle Aged, Predictive Value of Test, Retrospective Studie, Skin Neoplasm, Time Factor, Treatment Outcome, Up-Regulation
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/33812141; info:eu-repo/semantics/altIdentifier/wos/WOS:000647678000001; volume:149; firstpage:1; lastpage:10; journal:EUROPEAN JOURNAL OF CANCER; http://hdl.handle.net/11380/1259113Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85105295200